MedPath

Phenylephrine Tumescence for Hemostasis in Surgery for Burn Injury

Phase 1
Recruiting
Conditions
Blood Loss, Surgical
Interventions
Registration Number
NCT01731444
Lead Sponsor
University of Manitoba
Brief Summary

The standard of care for treatment of burn injury is to inject a solution of epinephrine under the skin of the injured site in order to reduce blood loss during skin grafting. This solution of epinephrine has been shown to have effects on the body outside the donor site. Some people have increases in heart rate and blood pressure. We will study the effect of a phenylephrine solution in place of an epinephrine solution to control blood loss. We think that phenylephrine will help decrease blood loss and not change blood pressure or heart rate.

The injured area will be injected under the skin and a skin graft will be taken in the same way as we usually do. The only change will be the use of phenylephrine in the solution instead of epinephrine.

Our goal is to find whether or not phenylephrine or epinephrine solution results in a reduction of blood loss without affecting the rest of the body.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
24
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
PhenylephrinePhenylephrine20 ug/cc
EpinephrinePhenylephrine1:1000000
Primary Outcome Measures
NameTimeMethod
Mean arterial blood pressure (MAP)during first 30 minutes

Mean arterial blood pressure

Secondary Outcome Measures
NameTimeMethod
Heart Rateq15 min

Recorded:

* just prior to induction of anesthesia

* maximum heart rate during time of procedure

* minimum heart rate during time of procedure

Blood Pressureq15 min

Cut off for safety: Diastolic \>140 or Systolic \>180;

Recorded:

* just prior to induction of anesthesia

* maximum heart rate during time of procedure

* minimum heart rate during time of procedure

Trial Locations

Locations (1)

University of Manitoba

🇨🇦

Winnipeg, Manitoba, Canada

© Copyright 2025. All Rights Reserved by MedPath